Top Clinical Trials companies in India by EBIT Margin
India
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
49.41%
|
March 31, 2024 | USD 1.29 | 2.70% |
|
India |
|
| 2 |
24.02%
|
March 31, 2024 | USD 32.88 | -0.93% |
|
India |
|
| 3 |
18.88%
|
March 31, 2024 | USD 8.61 | -1.79% |
|
India |
|
| 4 |
17.74%
|
March 31, 2024 | USD 9.86 | 2.71% |
|
India |
|
| 5 |
17.68%
|
March 31, 2024 | USD 9.20 | 2.64% |
|
India |
|
| 6 |
16.79%
|
March 31, 2024 | USD 6.91 | -0.24% |
|
India |
|
| 7 |
16.77%
|
March 31, 2024 | USD 20.71 | -0.50% |
|
India |
|
| 8 |
6.42%
|
March 31, 2024 | USD 11.23 | 1.68% |
|
India |
|
| 9 |
4.68%
|
March 31, 2024 | USD 16.75 | 0.23% |
|
India |
|
| 10 |
2.80%
|
March 31, 2024 | USD 0.59 | -0.38% |
|
India |
|
| 11 |
-172.17%
|
March 31, 2024 | USD 0.14 | 3.84% |
|
India |
|
| 12 |
-510.50%
|
March 31, 2024 | USD 1.84 | 1.24% |
|
India |
|
| 13 |
-898.78%
|
March 31, 2024 | USD 1.48 | 10.54% |
|
India |
Frequently Asked Questions
-
Which Clinical Trials company in India has the highest EBIT Margin ?
The Clinical Trials company in India with the highest EBIT Margin is Ind-Swift Laboratories Limited (NSE: INDSWFTLAB.NS) at 49.41%.
-
Which Clinical Trials company in India has the lowest EBIT Margin ?
The Clinical Trials company in India with the lowest EBIT Margin is Suven Life Sciences Limited (NSE: SUVEN.NS) at -898.78%.
-
What are the top 10 Clinical Trials companies in India by EBIT Margin ?
The top 10 Clinical Trials companies in India by EBIT Margin are Ind-Swift Laboratories Limited, Dr. Lal PathLabs Limited, Syngene International Limited, Vimta Labs Limited, Thyrocare Technologies Limited, Indegene Limited, Metropolis Healthcare Limited, Jubilant Pharmova Limited, Glenmark Pharmaceuticals Limited and Vineet Laboratories Limited.
-
What are the bottom 10 Clinical Trials companies in India by EBIT Margin ?
The bottom 10 Clinical Trials companies in India by EBIT Margin are Suven Life Sciences Limited, Sun Pharma Advanced Research Company Limited, TAKE Solutions Limited, Vineet Laboratories Limited, Glenmark Pharmaceuticals Limited, Jubilant Pharmova Limited, Metropolis Healthcare Limited, Indegene Limited, Thyrocare Technologies Limited and Vimta Labs Limited.
